跳至主要内容
临床试验/NCT03822104
NCT03822104已完成不适用

Bovine Colostrum to Fortify Human Milk for Preterm Infants: A Randomized, Controlled Trial

Per Torp Sangild2 个研究点 分布在 1 个国家目标入组 139 人开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
139
试验地点
2
主要终点
Incidence of feeding intolerance

研究概览

简要总结

Very preterm infants (<32 weeks gestation) show the immaturity of organs and have high nutrient requirements for growth and development. In the first weeks, they have difficulties tolerating enteral nutrition (EN) and are often given supplemental parenteral nutrition (PN). A fast transition to full EN is important to improve gut maturation and reduce the high risk of late-onset sepsis (LOS), related to their immature immunity in gut and blood. Conversely, too fast increase of EN predisposes to feeding intolerance and necrotizing enterocolitis (NEC). Further, human milk feeding is not sufficient to support nutrient requirements for growth of very preterm infants. Thus, it remains a difficult task to optimize EN transition, achieve adequate nutrient intake and growth, and minimize NEC and LOS in the postnatal period of very preterm infants. Mother´s own milk (MM) is considered the best source of EN for very preterm infants and pasteurized human donor milk (DM) is the second choice if MM is absent or not sufficient. The recommended protein intake is 4-4.5 g/kg/d for very low birth infants when the target is a postnatal growth similar to intrauterine growth rates. This amount of protein cannot be met by feeding only MM or DM. Thus, it is common practice to enrich human milk with human milk fortifiers (HMFs, based on ingredients used in infant formulas) to increase growth, bone mineralization and neurodevelopment, starting from 7-14 d after birth and 80-160 ml/kg feeding volume per day. Bovine colostrum (BC) is the first milk from cows after parturition and is rich in protein (80-150 g/L) and bioactive components. These components may improve gut maturation, NEC protection, and nutrient assimilation, even across species. Studies in preterm pigs show that feeding BC alone, or DM fortified with BC, improves growth, gut maturation, and NEC resistance during the first 1-2 weeks, relative to DM, or DM fortified with conventional HMFs. On this background, the investigators hypothesize that BC, used as a fortifier for MM or DM, can reduce feeding intolerance than conventional fortifiers.

详细描述

Objectives

  1. To test if fortification of human milk with BC reduces feeding intolerance compared with currently used HMF.
  2. To verify the safety and tolerability of BC fortification and to monitor the rates of growth, NEC and sepsis, as investigated in a parallel trial in Denmark

Trial design This study is a dual-center, non-blinded, two-armed, randomized, controlled trial.

Participants Parents to eligible very preterm infants admitted to the Neonatal Intensive Care Units (NICU) at Nanshan People's Hospital (NAN) and Baoan Maternal and Children's Hospital in Shenzhen, China will be asked for participation.

Sample size 68 infants per group, 136 in total

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
5 Days 至 3 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Very preterm infants born between gestational age 26 + 0 and 30 + 6 weeks (from the first day of the mother's last menstrual period and/or based on fetal ultrasound)
  • DM is given at the unit when MM is absent (or insufficient in amount)
  • Infants judged by the attending physician to be in need of nutrient fortification, as added in the form of HMF to MM and/or DM
  • Signed parental consent

排除标准

  • Major congenital anomalies and birth defects
  • Infants who have had gastrointestinal surgery prior to randomization
  • Infants who have received IF prior to randomization

结局指标

主要结局

Incidence of feeding intolerance

时间窗: From start of intervention until the infants reach PMA 35+6 weeks or are not in need of fortification due to sufficient growth, whichever comes first

Number of infants in each group diagnosed with feeding intolerance for at least once. Feeding intolerance is defined as any pause of fortification or withhold of enteral feeding.

次要结局

  • Time to reach full enteral feeding(From birth to hospital discharge, or up to 14 weeks)
  • Days on parenteral nutrition(From birth to hospital discharge, or up to 14 weeks)
  • Length of hospital stay(From birth to hospital discharge, or up to 14 weeks)
  • Body weight(Measured weekly from the start of intervention until hospital discharge, or up to 14 weeks)
  • Body length(Measured weekly from the start of intervention until hospital discharge, or up to 14 weeks)
  • Head circumference(Measured weekly from the start of intervention until hospital discharge, or up to 14 weeks)
  • Incidence of necrotizing entercolitis (NEC)(From the start of intervention to hospital discharge, or up to 14 weeks)
  • Incidence of late-onset sepsis (LOS)(From the start of intervention to hospital discharge, or up to 14 weeks)

研究者

发起方
Per Torp Sangild
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Per Torp Sangild

Professor

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验

Bovine Colostrum as a Human Milk Fortifier for... | 临床试验